SNIOF yields 20000000.00% · PFE yields 6.13%● Live data
📍 SNIOF pulled ahead of the other in Year 1
Combined, SNIOF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNIOF + PFE for your $10,000?
SENSIO Technologies Inc. develops and markets stereoscopic technologies for consumer electronics, digital broadcasting, digital cinema, and semiconductor markets. It offers SENSIO Hi-Fi 3D that renders fidelity to the originally-captured images for 3D content delivered over cable, satellite, or the Internet; SENSIO 3D Encoder family solutions for encoding stereoscopic 3D signals into frame-compatible formats; and SENSIO 3D Decoder family solutions for decoding frame-compatible 3D formats. The company also provides SENSIO Autodetect that provides automatic format detection without the need for end-user intervention; and SENSIO Noise Reducer that is designed to remove video noises, including discrete cosine transfer artifacts and various random noises, as well as offers content solutions comprising 3DGO!, a 3D video-on-demand service. It has operations in North America, Europe, and Asia. The company was founded in 1999 and is based in Montreal, Canada.
Full SNIOF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.